1. Home
  2. DCBO vs VALN Comparison

DCBO vs VALN Comparison

Compare DCBO & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCBO
  • VALN
  • Stock Information
  • Founded
  • DCBO 2016
  • VALN 2012
  • Country
  • DCBO Canada
  • VALN France
  • Employees
  • DCBO N/A
  • VALN N/A
  • Industry
  • DCBO
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DCBO
  • VALN Health Care
  • Exchange
  • DCBO Nasdaq
  • VALN Nasdaq
  • Market Cap
  • DCBO 783.3M
  • VALN 777.9M
  • IPO Year
  • DCBO 2020
  • VALN 2021
  • Fundamental
  • Price
  • DCBO $26.75
  • VALN $9.94
  • Analyst Decision
  • DCBO Strong Buy
  • VALN Strong Buy
  • Analyst Count
  • DCBO 6
  • VALN 4
  • Target Price
  • DCBO $41.33
  • VALN $15.75
  • AVG Volume (30 Days)
  • DCBO 55.9K
  • VALN 66.2K
  • Earning Date
  • DCBO 11-07-2025
  • VALN 11-06-2025
  • Dividend Yield
  • DCBO N/A
  • VALN N/A
  • EPS Growth
  • DCBO 33.51
  • VALN N/A
  • EPS
  • DCBO 0.69
  • VALN N/A
  • Revenue
  • DCBO $230,502,000.00
  • VALN $230,566,060.00
  • Revenue This Year
  • DCBO $13.02
  • VALN $15.69
  • Revenue Next Year
  • DCBO $8.37
  • VALN $22.15
  • P/E Ratio
  • DCBO $35.21
  • VALN N/A
  • Revenue Growth
  • DCBO 15.11
  • VALN 25.47
  • 52 Week Low
  • DCBO $25.50
  • VALN $3.62
  • 52 Week High
  • DCBO $53.86
  • VALN $12.25
  • Technical
  • Relative Strength Index (RSI)
  • DCBO 39.45
  • VALN 45.76
  • Support Level
  • DCBO $25.69
  • VALN $10.08
  • Resistance Level
  • DCBO $27.23
  • VALN $10.55
  • Average True Range (ATR)
  • DCBO 0.60
  • VALN 0.37
  • MACD
  • DCBO -0.02
  • VALN -0.18
  • Stochastic Oscillator
  • DCBO 45.40
  • VALN 4.60

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: